Cargando…

The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene

Interferon (IFN) therapy is effective in treating cancers, haematological and virus induced diseases. The classical Jak/Stat pathway of IFN signal transduction leading to changes in transcriptional activity is well established but alone does not explain the whole spectrum of cellular responses to IF...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Steven, Kawamoto, Shota, Tanuma, Sei-ichi, Uchiumi, Fumiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672336/
https://www.ncbi.nlm.nih.gov/pubmed/26643049
http://dx.doi.org/10.1038/srep17497
_version_ 1782404551218823168
author Larsen, Steven
Kawamoto, Shota
Tanuma, Sei-ichi
Uchiumi, Fumiaki
author_facet Larsen, Steven
Kawamoto, Shota
Tanuma, Sei-ichi
Uchiumi, Fumiaki
author_sort Larsen, Steven
collection PubMed
description Interferon (IFN) therapy is effective in treating cancers, haematological and virus induced diseases. The classical Jak/Stat pathway of IFN signal transduction leading to changes in transcriptional activity is well established but alone does not explain the whole spectrum of cellular responses to IFN. Gene promoters contain cis-acting sequences that allow precise and contextual binding of transcription factors, which control gene expression. Using the transcriptional response to IFN as a starting point we report a high frequency of tandem GGAA motifs in the proximal promoters of Interferon stimulated genes, suggesting a key regulatory action. Utilizing the well-characterized anti-viral gene, OAS1, as an example Interferon stimulated gene promoter containing such a duplicated GGAA motif, we have demonstrated a regulatory role of this promoter in response to IFN by mutation analysis. Furthermore, we identified ELF-1 as a direct binding factor at this motif. Additionally, recruitment of RB1 and SP1 factors to the promoter following IFN stimulation is shown. ELF-1 overexpression enhanced and knockdown of ELF-1 inhibited full activation of OAS1 by IFN stimulation. Collectively, ELF-1 binds an important duplicated GGAA cis-acting element at the OAS1 promoter and in cooperation with RB1 and SP1 recruitment contributes to regulation in response to IFN stimulation.
format Online
Article
Text
id pubmed-4672336
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46723362015-12-11 The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene Larsen, Steven Kawamoto, Shota Tanuma, Sei-ichi Uchiumi, Fumiaki Sci Rep Article Interferon (IFN) therapy is effective in treating cancers, haematological and virus induced diseases. The classical Jak/Stat pathway of IFN signal transduction leading to changes in transcriptional activity is well established but alone does not explain the whole spectrum of cellular responses to IFN. Gene promoters contain cis-acting sequences that allow precise and contextual binding of transcription factors, which control gene expression. Using the transcriptional response to IFN as a starting point we report a high frequency of tandem GGAA motifs in the proximal promoters of Interferon stimulated genes, suggesting a key regulatory action. Utilizing the well-characterized anti-viral gene, OAS1, as an example Interferon stimulated gene promoter containing such a duplicated GGAA motif, we have demonstrated a regulatory role of this promoter in response to IFN by mutation analysis. Furthermore, we identified ELF-1 as a direct binding factor at this motif. Additionally, recruitment of RB1 and SP1 factors to the promoter following IFN stimulation is shown. ELF-1 overexpression enhanced and knockdown of ELF-1 inhibited full activation of OAS1 by IFN stimulation. Collectively, ELF-1 binds an important duplicated GGAA cis-acting element at the OAS1 promoter and in cooperation with RB1 and SP1 recruitment contributes to regulation in response to IFN stimulation. Nature Publishing Group 2015-12-08 /pmc/articles/PMC4672336/ /pubmed/26643049 http://dx.doi.org/10.1038/srep17497 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Larsen, Steven
Kawamoto, Shota
Tanuma, Sei-ichi
Uchiumi, Fumiaki
The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
title The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
title_full The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
title_fullStr The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
title_full_unstemmed The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
title_short The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
title_sort hematopoietic regulator, elf-1, enhances the transcriptional response to interferon-β of the oas1 anti-viral gene
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672336/
https://www.ncbi.nlm.nih.gov/pubmed/26643049
http://dx.doi.org/10.1038/srep17497
work_keys_str_mv AT larsensteven thehematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT kawamotoshota thehematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT tanumaseiichi thehematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT uchiumifumiaki thehematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT larsensteven hematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT kawamotoshota hematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT tanumaseiichi hematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene
AT uchiumifumiaki hematopoieticregulatorelf1enhancesthetranscriptionalresponsetointerferonboftheoas1antiviralgene